Related Experiment Video
Updated: Sep 20, 2025

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
Cancer- and cardiac-induced cachexia: same fate through different inflammatory mediators?
Rita Nogueira-Ferreira1, Fábio Sousa-Nunes2,3, Adelino Leite-Moreira2,4
1UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine, University of Porto, Alameda Professor Hernâni Monteiro, 4200-319, Porto, Portugal. rmferreira@med.up.pt.
Inflammation is linked to cachexia, but targeted therapies aren't always effective. This review identifies key inflammatory markers like IL-6 and CRP for diagnosis and monitoring cancer and cardiac cachexia.
Area of Science:
- Biomedical research
- Clinical diagnostics
- Pathophysiology
Background:
- Inflammation is a known driver of cachexia in chronic diseases.
- Therapies targeting inflammation do not consistently reverse cachexia, prompting debate on inflammation's role.
Purpose of the Study:
- To investigate the contribution of inflammatory markers to cachexia pathogenesis and diagnosis.
- Focus on noncommunicable diseases: cancer and cardiovascular diseases.
Main Methods:
- Systematic literature review in PubMed using specific keywords for cachexia biomarkers.
- Screening of 744 retrieved studies, with 98 papers on circulating biomarkers selected.
Main Results:
- Interleukin-6 (IL-6) and C-reactive protein (CRP) are key inflammatory markers for cachexia, useful for monitoring therapy.
- Specific markers identified: BNP, renin, obestatin for cardiac cachexia; GDF-15, TGF-β1, VEGF-C for cancer cachexia.
- NF-κB and JAK/STAT pathways link inflammation to muscle wasting, though targeted therapies show variable efficacy.
Conclusions:
- This analysis provides insights into cachexia pathogenesis, aiding diagnosis and personalized therapy development.
- Future research should focus on understanding specific cachexia phenotypes for targeted interventions.
Related Concept Videos
Myocarditis I: Introduction
The Tumor Microenvironment
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Inflammation
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Pathophysiology of Heart Failure

